PNNL chemist Ying Zhu was honored as one of the top 40 researchers under the age of 40 in analytical science by The Analytical Scientist.

PNNL experts in nuclear forensics helped lead laboratories around the world through a rigorous test involving nuclear materials.

The Washington State Academy of Sciences added six people from PNNL to its 2022 class of inductees.

The size of the alkali metal within the material influences the crystallization pathway.

Two PNNL teams have been recognized for their work on safe, secure radioactive material shipping.

Researchers use machine learning to speed up the analysis of aerosol datasets from mass spectrometry.

Combining advanced powder synthesis with solid state processing allows researchers to streamline oxide dispersion-strengthened steel fabrication.

PNNL scientists have developed a new mass spectrometry method for in-depth analysis of proteins in individual cells.

Data from increasingly complex mass spectrometry instruments met with adaptable data analysis solution.

Proteomics revealed molecular mechanisms by which the drug Verapamil could prolong beta cell function in early-onset type 1 diabetes patients.

Different sized helium cavities that form after ion irradiation are unevenly distributed in a ductile-phase toughened tungsten composite.

A PNNL team is leading the design, fabrication, and regulatory testing, and delivery of new packaging units that will be used to ship radioactive materials safely and securely.

Study highlights microbiome’s role in regulating xenobiotic metabolism.

Mowei Zhou, a chemist with the Environmental Molecular Sciences Laboratory, is speaking at the ACS spring conference on his latest protein discoveries for a plant that could transform biofuels production.

Development of a one-meter path length miniature ion mobility spectrometer based on multilevel structures for lossless ion manipulations.

Governor Inslee announced the appointment of Karin Rodland to the Board of Directors of the Andy Hill Cancer Research Endowment Fund.

Studying MERS-CoV may lead to better treatments for a host of respiratory illnesses, including the many variants of COVID-19.

PNNL scientists are protecting first responders and others by expanding what’s known about fentanyl, the driver of the opioid epidemic.

Researchers characterize protein signatures that indicate Acute Kidney Injury in COVID-19 patients.

PNNL scientists publish paper and host workshops to share threat-agnostic vision for biodefense.